Avinger, Inc. (AVGR)
| Market Cap | 12.26M |
| Revenue (ttm) | 8.79M |
| Net Income (ttm) | -28.71M |
| Shares Out | 7.04M |
| EPS (ttm) | -5.60 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 127,074 |
| Open | 1.81 |
| Previous Close | 1.84 |
| Day's Range | 1.74 - 1.89 |
| 52-Week Range | 1.40 - 19.26 |
| Beta | 1.67 |
| Analysts | Buy |
| Price Target | 7.65 (+339.4%) |
| Earnings Date | Aug 11, 2022 |
About AVGR
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as w... [Read more...]
Financial Performance
In 2021, Avinger's revenue was $10.13 million, an increase of 15.63% compared to the previous year's $8.76 million. Losses were -$17.41 million, -8.39% less than in 2020.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for AVGR stock is "Buy." The 12-month stock price forecast is 7.65, which is an increase of 339.40% from the latest price.
News
Avinger Reports Second Quarter 2022 Results
REDWOOD CITY, CA / ACCESSWIRE / August 11, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-...
Avinger, Inc. Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-the-Market ...
REDWOOD CITY, CA / ACCESSWIRE / August 8, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company developing and marketing the first and only intravascular image-gu...
Avinger to Announce Second Quarter 2022 Results on August 11
REDWOOD CITY, CA / ACCESSWIRE / August 5, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
Avinger Announces $5 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
REDWOOD CITY, CA / ACCESSWIRE / August 4, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-b...
Avinger Announces Filing of 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System
REDWOOD CITY, CA / ACCESSWIRE / July 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
Avinger Expands International Presence with First Commercial Shipment to Chile
REDWOOD CITY, CA / ACCESSWIRE / June 21, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...
Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022
REDWOOD CITY, CA / ACCESSWIRE / June 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
REDWOOD CITY, CA / ACCESSWIRE / June 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany
REDWOOD CITY, CA / ACCESSWIRE / May 16, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
Avinger (AVGR) Reports Q1 Loss, Misses Revenue Estimates
Avinger (AVGR) delivered earnings and revenue surprises of -92.56% and 0.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Avinger Reports First Quarter 2022 Results
REDWOOD CITY, CA / ACCESSWIRE / May 10, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-bas...
Avinger to Announce First Quarter 2022 Results on May 10
REDWOOD CITY, CA / ACCESSWIRE / April 29, 2022 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
Avinger Announces Full Commercial Launch of Lightbox 3
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-b...
Avinger Announces Issuance of Three New U.S. Patents in March 2022
16 New U.S. and International Patents Issued over Past Year REDWOOD CITY, CA / ACCESSWIRE / March 30, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketi...
Avinger Regains Compliance with Nasdaq Listing Requirements
REDWOOD CITY, CA / ACCESSWIRE / March 29, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
Avinger (AVGR) Reports Q4 Loss, Tops Revenue Estimates
Avinger (AVGR) delivered earnings and revenue surprises of 0% and 4.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Avinger Registers 12% Decline In Q4 Revenue, Says Hospital Constraints Impacted Q4
Avinger Inc (NASDAQ: AVGR) reported a fourth-quarter revenue decrease of 12% year-over-year to $2.40 million, beating the consensus of $2.29 million. Hospital constraints impacted Q4 on procedural volum...
Avinger Reports Fourth Quarter and Year End 2021 Results
REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-b...
Avinger to Announce Full-Year 2021 Results on March 22
REDWOOD CITY, CA / ACCESSWIRE / March 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
Avinger to Effect One-for-Twenty Reverse Stock Split
REDWOOD CITY, CA / ACCESSWIRE / March 14, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
Avinger Expands Lightbox 3 First Case Experience
Patients Treated in Four Additional Hospitals Using New Portable System REDWOOD CITY, CA / ACCESSWIRE / March 7, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing t...
Avinger Announces Successful Completion of First Cases with the Lightbox 3 Next Generation Imaging Console
REDWOOD CITY, CA / ACCESSWIRE / February 28, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system ...
Avinger Announces Closing of $7.6 Million Registered Direct Offering
REDWOOD CITY, CA / ACCESSWIRE / January 14, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company marketing the first and only intravascular image-guided, cathete...
Avinger Announces $7.6 Million Registered Direct Offering
REDWOOD CITY, CA / ACCESSWIRE / January 12, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company marketing the first and only intravascular image-guided, cathete...
Avinger Announces 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console
REDWOOD CITY, CA / ACCESSWIRE / January 11, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system f...